AlphaGenome Paper Is Candid About Limits; the Marketing Hype Is Still Within Bounds
anshulkundaje · x · 2026-09-18
The AlphaGenome authors are clear about relative improvements and limitations in the paper. DeepMind's marketing hype is less nuanced, but compared to what is typical in the field it remains within bounds.
More from Companies & People
- Astra for Law posts big legal benchmark gains as Mollick asks if labs will eat every AI vertical — emollick · 2026-09-18
- Beff Jezos: Sama is likely enjoying the backlash against EAs and safetyists after their coup attempt — beffjezos · 2026-09-18
- Dollhouse Robotics bets on humanoid robots for event services: real revenue, fast iteration today — carlosdponx · 2026-09-18
- Virtual cell model researcher joins Cellular Intelligence to transform cell therapies — arjunrajlab · 2026-09-18
- Former product SVP goes solo founder, leads a team of AI agents to build her product — DynamicWebPaige · 2026-09-18
- Steve Eisman: AI firms have no moats and are manufacturing a crisis to shape regulation — GaryMarcus · 2026-09-18